D-Index & Metrics Best Publications
Research.com 2022 Best Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Psychology D-index 139 Citations 74,919 614 World Ranking 56 National Ranking 33
Medicine D-index 152 Citations 97,948 842 World Ranking 395 National Ranking 242
Best Scientists D-index 159 Citations 104,643 983 World Ranking 875 National Ranking 559

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Scientist Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Major depressive disorder
  • Psychiatry

Michael E. Thase focuses on Psychiatry, Depression, Major depressive disorder, Internal medicine and Randomized controlled trial. Many of his studies on Psychiatry apply to Clinical psychology as well. His Depression research incorporates elements of Psychotherapist, Imipramine, Pharmacotherapy and Cognition.

His Major depressive disorder research is multidisciplinary, relying on both Venlafaxine, Citalopram, STAR*D and Mood disorders. The study incorporates disciplines such as Placebo, Fluoxetine, Paroxetine, Sertraline and Reuptake inhibitor in addition to Internal medicine. Michael E. Thase focuses mostly in the field of Randomized controlled trial, narrowing it down to topics relating to Clinical trial and, in certain cases, Treatment-resistant depression.

His most cited work include:

  • Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2853 citations)
  • The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. (2157 citations)
  • A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. (1078 citations)

What are the main themes of his work throughout his whole career to date?

Michael E. Thase mostly deals with Psychiatry, Depression, Major depressive disorder, Internal medicine and Clinical psychology. Within one scientific family, Michael E. Thase focuses on topics pertaining to Randomized controlled trial under Psychiatry, and may sometimes address concerns connected to Clinical trial. His Depression study incorporates themes from Rating scale, Cognition, Psychotherapist, Severity of illness and Comorbidity.

His Major depressive disorder study combines topics in areas such as Citalopram, Anesthesia and Major depressive episode. His Internal medicine research is multidisciplinary, incorporating perspectives in Venlafaxine, Placebo and Fluoxetine. His study looks at the intersection of Clinical psychology and topics like Cognitive therapy with Cognitive behavioral therapy.

He most often published in these fields:

  • Psychiatry (63.58%)
  • Depression (50.05%)
  • Major depressive disorder (36.89%)

What were the highlights of his more recent work (between 2014-2021)?

  • Major depressive disorder (36.89%)
  • Depression (50.05%)
  • Psychiatry (63.58%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Major depressive disorder, Depression, Psychiatry, Internal medicine and Clinical psychology. His research in Major depressive disorder intersects with topics in Clinical trial, Adverse effect, Randomized controlled trial, Placebo and Major depressive episode. His biological study spans a wide range of topics, including Physical therapy and Pharmacotherapy.

His work on Antidepressant, Bipolar disorder, Brexpiprazole and Anxiety as part of general Psychiatry study is frequently linked to Suicidal ideation, therefore connecting diverse disciplines of science. His study on Clinical endpoint, Tolerability and Post-hoc analysis is often connected to Pharmacogenomic Testing as part of broader study in Internal medicine. He has included themes like Insomnia, Interpersonal relationship, Cognition and Depressive symptoms in his Clinical psychology study.

Between 2014 and 2021, his most popular works were:

  • Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial (224 citations)
  • Common and Dissociable Dysfunction of the Reward System in Bipolar and Unipolar Depression (132 citations)
  • Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study (131 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Major depressive disorder
  • Psychiatry

His main research concerns Depression, Psychiatry, Major depressive disorder, Internal medicine and Bipolar disorder. His Depression research incorporates themes from Affect, Rating scale, Meta-analysis, Clinical psychology and PsycINFO. He performs multidisciplinary study on Psychiatry and Suicidal ideation in his works.

The various areas that Michael E. Thase examines in his Major depressive disorder study include Adjunctive treatment, Tolerability, Adverse effect, Cognitive behavioral therapy and Cognitive therapy. His studies deal with areas such as Placebo and Esketamine as well as Internal medicine. His Bipolar disorder research is multidisciplinary, incorporating elements of Lithium, Quetiapine, Mood, Ventral striatum and Mood disorders.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

A. John Rush;Madhukar H. Trivedi;Stephen R. Wisniewski;Andrew A. Nierenberg.
American Journal of Psychiatry (2006)

4090 Citations

The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

A.John Rush;Madhukar H Trivedi;Hicham M Ibrahim;Thomas J Carmody.
Biological Psychiatry (2003)

3493 Citations

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

Martin B. Keller;James P. McCullough;Daniel N. Klein;Bruce Arnow.
The New England Journal of Medicine (2000)

1824 Citations

Five-Year Outcome for Maintenance Therapies in Recurrent Depression

David J. Kupfer;Ellen F. Frank;James M. Perel;Cleon Cornes.
Archives of General Psychiatry (1990)

1699 Citations

PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder

Alan J. Gelenberg;P. Freeman;John C. Markowitz;Jerrold F. Rosenbaum.
(2010)

1341 Citations

The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression

Robert M.A. Hirschfeld;Martin B. Keller;Susan Panico;Bernard S. Arons.
JAMA (1997)

1271 Citations

Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder

Manuel A R Ferreira;Michael C O'Donovan;Yan A Meng;Ian R Jones.
Nature Genetics (2008)

1211 Citations

Medication Augmentation after the Failure of Ssris for Depression

Madhukar H Trivedi;Maurizio Fava;Stephen R. Wisniewski;Michael E. Thase.
The New England Journal of Medicine (2006)

1168 Citations

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

A. John Rush;Madhukar H. Trivedi;Stephen R. Wisniewski;Jonathan W. Stewart.
The New England Journal of Medicine (2006)

1161 Citations

Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression

Gary S. Sachs;Andrew A. Nierenberg;Joseph R. Calabrese;Lauren B. Marangell.
The New England Journal of Medicine (2007)

1137 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael E. Thase

Maurizio Fava

Maurizio Fava

Harvard University

Publications: 317

Madhukar H. Trivedi

Madhukar H. Trivedi

The University of Texas Southwestern Medical Center

Publications: 314

Eduard Vieta

Eduard Vieta

University of Barcelona

Publications: 266

Roger S. McIntyre

Roger S. McIntyre

University Health Network

Publications: 215

Michael Berk

Michael Berk

Deakin University

Publications: 196

Sidney H. Kennedy

Sidney H. Kennedy

University Health Network

Publications: 185

Andrew A. Nierenberg

Andrew A. Nierenberg

Harvard University

Publications: 174

Ellen Frank

Ellen Frank

University of Pittsburgh

Publications: 173

Siegfried Kasper

Siegfried Kasper

Medical University of Vienna

Publications: 170

David J. Kupfer

David J. Kupfer

University of Pittsburgh School of Medicine

Publications: 165

Gin S Malhi

Gin S Malhi

University of Sydney

Publications: 163

Allan H. Young

Allan H. Young

South London and Maudsley NHS Foundation Trust

Publications: 158

Michael Bauer

Michael Bauer

TU Dresden

Publications: 150

Mikael Landén

Mikael Landén

University of Gothenburg

Publications: 148

A. John Rush

A. John Rush

Duke University

Publications: 147

Alessandro Serretti

Alessandro Serretti

University of Bologna

Publications: 135

Trending Scientists

Zheng Yan

Zheng Yan

Shanghai Jiao Tong University

Chris Welty

Chris Welty

Google (United States)

John W. Polak

John W. Polak

Imperial College London

Foster B. Stulen

Foster B. Stulen

Johnson & Johnson (United States)

Yoshinobu Tsujii

Yoshinobu Tsujii

Kyoto University

Srinivasan Natarajan

Srinivasan Natarajan

Indian Institute of Science Bangalore

Shan X. Wang

Shan X. Wang

Stanford University

Jochen Schöngart

Jochen Schöngart

National Institute of Amazonian Research

Peeter Nõges

Peeter Nõges

Estonian University of Life Sciences

Kim E. Barrett

Kim E. Barrett

University of California, San Diego

James R. Brown

James R. Brown

GlaxoSmithKline (United Kingdom)

M. Alexander Schmidt

M. Alexander Schmidt

University of Münster

Michael E Weber

Michael E Weber

University of Bonn

Robert Gallop

Robert Gallop

West Chester University

Edward C. Benzel

Edward C. Benzel

Cleveland Clinic

Jens Limpert

Jens Limpert

Friedrich Schiller University Jena

Something went wrong. Please try again later.